Carta al DirectorMeningitis por Listeria monocytogenes durante tratamiento con adalimumabMeningitis due to Listeria monocytogenes during adalimumab therapy
Bibliografía (9)
- et al.
Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn's disease: The CLASSIC-I trial
Gastroenterology
(2006) - et al.
Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: The CHARM trial
Gastroenterology
(2007) - et al.
Adalimumab for maintenance treatment of Crohn's disease: Results of the CLASSIC II trial
Gut
(2007) - et al.
Adalimumab induction therapy for Crohn disease previously treated with infliximab
Ann Internal Med
(2007)
There are more references available in the full text version of this article.
Cited by (0)
Copyright © 2009 Elsevier España, S.L. All rights reserved.